Volume 17, Number 7—July 2011
Research
Hansen Disease among Micronesian and Marshallese Persons Living in the United States
Table 1
Population group |
No. (%) patients |
Median time from US entry to report, y (range) |
MDT,†
no. (%) |
Complications, no. cases |
||||||||
Total |
MB |
F |
Age <15 y |
ENL |
RR |
Hand/foot neuropathy |
Eye |
Other |
Any
(%)‡ |
|||
Hawaii-residing Micronesians, 2000–2009§ | 29 | 22 (76) | 5 (17) | 3 (10) | 1.5 (0–13) | NA | NA | NA | NA | NA | NA | NA |
Hawaii-residing Marshallese, 2000–2009§ | 43 | 31 (72) | 17 (39) | 1 (2) | 1 (0–14) | NA | NA | NA | NA | NA | NA | NA |
US Mainland Micronesians, 1990–2009 | 55 | 42 (76) | 10 (18) | 6 (10) | 3 (0–10) | 10 (42) | 15 | 3 | 8 | 6 | 3¶ | 25 (77) |
US Mainland Marshallese, 1990–2009 | 33 | 25 (76) | 11 (33) | 3 (10) | 2 (0–12) | 7 (32) | 6 | 3 | 5 | 1 | 1# | 12 (75) |
Arkansas-residing Marshallese, 1990–2009 | 17 | 15 (88) | 5 (30) | 0 (0) | 2 (0–5) | 3 (20) | 4 | 2 | 2 | 0 | 0 | 12 (70) |
*Data from National Hansen’s Disease Program surveillance and clinical records, January 1990–October 2009. MB, multibacillary; MDT, multidrug therapy; ENL, erythema nodosum leprosum; RR, reversal reaction; NA, data not available.
†MDT completed, excluding patients currently under active treatment.
‡Patients for whom clinical data were available.
§Pre-2000 data were not reported to National Hansen’s Disease Program.
¶1 renal, 1 testicular, 1 palatal.
#1 renal.
Page created: August 18, 2011
Page updated: August 18, 2011
Page reviewed: August 18, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.